Latest AI and machine learning research in skin cancer for healthcare professionals.
Non-small cell lung cancer (NSCLC) presents persistent challenges in immunotherapy, as the clinical ...
Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, remains a major global...
The immunosuppressive tumor microenvironment (TME) enables cancer cells to evade clinical immunother...
BACKGROUND: Cancer-associated fibroblasts (CAFs) are key players in the tumor microenvironment (TME)...
The gut microbiome is recognized as a determinant of response to immune checkpoint inhibitor (ICI) t...
Direct reprogramming of immune cells holds promise for immunotherapy but is constrained by limited k...
The rapid development of multimodal large language models (LLMs) such as GPT and Med-PaLM is reshapi...
Chimeric antigen receptor T-cell (CAR-T) therapy has achieved unprecedented success in hematological...
PURPOSE: This study aims to develop an artificial intelligence (AI) model to assist ophthalmologists...
RNA therapeutics have come of age as clinically validated modalities including mRNA, siRNA, antisens...
Melanoma, an aggressive form of skin cancer, demands innovative immunotherapeutic strategies to impr...
Cancer cells face a hostile microenvironment characterized by hypoxia, nutrient deprivation, endopla...
Neoadjuvant immunochemotherapy (NAIC) is a standard treatment for triple-negative breast cancer (TNB...
Tumor-intrinsic biomarkers alone insufficiently predict pathological complete response (pCR) to neoa...
Ultraviolet (UV) radiation is the primary risk factor for the development of both melanocytic and no...
Neutrophil extracellular traps (NETs) have emerged as key modulators in the tumor microenvironment, ...
Investigating the transcriptional signatures of immune cells in various cancer types is crucial for ...
Metabolic alterations and immune dysfunction within the gastric tumor microenvironment critically dr...
Multidisciplinary team (MDT) discussions have become a cornerstone of colorectal cancer (CRC) manage...
BACKGROUND AND OBJECTIVE: Relapse in Multiple Myeloma, driven by therapy-resistant cancer stem cells...
Early-onset colorectal cancer (EOCRC), diagnosed in patients under 50, is particularly aggressive, y...